Article Details

Ironwood Pharmaceuticals (NASDAQ:IRWD) Rating Increased to Buy at Zacks Investment Research

Retrieved on: 2021-04-20 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

Ironwood Pharmaceuticals (NASDAQ:IRWD) Rating Increased to Buy at Zacks Investment Research. View article details on hiswai:

Excerpt

Renaissance Technologies LLC increased its position in shares of Ironwood Pharmaceuticals by 118.6% during the fourth quarter. Renaissance ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up